Call for the international adoption of microbiological breakpoints for fluoroquinolones and Streptococcus pneumoniae

This publication has 7 references indexed in Scilit:

• Are fluoroquinolone-susceptible isolates of Streptococcus pneumoniae really susceptible? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003
  Journal of Antimicrobial Chemotherapy, 2005
• A Review of Streptococcus pneumoniae Infection Treatment Failures Associated with Fluoroquinolone Resistance
  Clinical Infectious Diseases, 2005
• Designing Fluoroquinolone Breakpoints for Streptococcus pneumoniae by Using Genetics instead of Pharmacokinetics-Pharmacodynamics
  Antimicrobial Agents and Chemotherapy, 2004
• Quinolone Resistance among Pneumococci: Therapeutic and Diagnostic Implications
  Clinical Infectious Diseases, 2004
• Molecular characterization of fluoroquinolone resistant Streptococcus pneumoniae clinical isolates obtained from across Canada
  Diagnostic Microbiology and Infectious Disease, 2003
• Resistance to Levofloxacin and Failure of Treatment of Pneumococcal Pneumonia
  New England Journal of Medicine, 2002
• Prevalence of Single Mutations in Topoisomerase Type II Genes among Levofloxacin-Susceptible Clinical Strains of Streptococcus pneumoniae Isolated in the United States in 1992 to 1996 and 1999 to 2000
  Antimicrobial Agents and Chemotherapy, 2002